Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization.
about
Protection against a lethal avian influenza A virus in a mammalian system.Secondary rearrangements and hypermutation generate sufficient B cell diversity to mount protective antiviral immunoglobulin responses.Neutralizing antibody fails to impact the course of Ebola virus infection in monkeysEnhanced virus clearance by early inducible lymphocytic choriomeningitis virus-neutralizing antibodies in immunoglobulin-transgenic miceMaternal immunity enhances Mycoplasma hyopneumoniae vaccination induced cell-mediated immune responses in pigletsAdditive effect of neutralizing antibody and antiviral drug treatment in preventing virus escape and persistence.Protective T-cell-based immunity induced in neonatal mice by a single replicative cycle of herpes simplex virusAn unexpected antibody response to an engineered influenza virus modifies CD8+ T cell responses.Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity.Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice.Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.Vesicular stomatitis virus-based therapeutic vaccination targeted to the E1, E2, E6, and E7 proteins of cottontail rabbit papillomavirusNonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread.Protective T cell-independent antiviral antibody responses are dependent on complement.Antiviral antibody responses: the two extremes of a wide spectrum.Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigensAntiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodiesUnderwhelming the immune response: effect of slow virus growth on CD8+-T-lymphocyte responses.Kinetics of protective antibodies are determined by the viral surface antigen.CTL induction by cross-priming is restricted to immunodominant epitopes.The price of the CD27-CD70 costimulatory axis: you can't have it all.Immunopathological basis of lymphocytic choriomeningitis virus-induced chorioretinitis and keratitis.Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain.Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral properties.
P2860
Q30432414-35434AFD-F6B0-4C72-9514-89C75AF8760DQ30708822-7ED89401-0271-499B-A261-D73CD513D292Q33269796-C6B44143-B633-4918-B213-F57F894F34F0Q33782446-EEE9E601-5807-43D3-90DD-DD0E7D89CBE7Q33786314-F4F818FD-48AF-48EF-9C8B-442F514E0068Q33806524-50B09687-31E0-4FE5-88C3-375CDC39B5C7Q33834517-0ED14AE4-14D6-4EDE-9539-FC16ED98F658Q34479840-6CE39F5F-5614-4E83-B7CB-49F36280C9C9Q35638608-1FCCD15E-4B31-4899-85E8-AE985C34207DQ35726474-7A4449AC-B2DD-4737-8920-A33077340FC5Q35847032-78553DE4-3853-4C52-AF3F-E7E7492C416DQ35857789-6A2B03CA-E112-442F-9EC9-EE1480D88FC2Q36228781-05CE5951-79C4-4226-B1C2-E9CF3B619C8CQ36375462-7115CBB3-E1BB-4442-9DD7-A02E504A97C3Q36405084-3F637D90-AF48-4886-8C20-C60415E652B9Q36473845-E0B7C24F-A790-451E-BDDC-355D16319333Q36689886-58DF29BE-7F59-4244-999D-1CD12BC60A88Q36954757-0B457980-B350-4F97-92B5-DAEF56E9E392Q37532751-217B6FB0-7805-4592-93D1-1A6ED31E6374Q39888117-FD74FA30-8AAE-4B4A-BC8D-5DB88607BD7AQ41773141-887598D7-378F-4303-BF1A-C5BCDFC00455Q41784773-7179F5C6-2AD0-469D-A762-5A622986CDDAQ42795549-EFDF80A5-6D29-4D9D-9C0C-A23DF67D7C97Q43899938-0EADED1E-9EAE-47ED-8AE5-54F326927645
P2860
Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Induction of protective cytoto ...... ssive and active immunization.
@ast
Induction of protective cytoto ...... ssive and active immunization.
@en
type
label
Induction of protective cytoto ...... ssive and active immunization.
@ast
Induction of protective cytoto ...... ssive and active immunization.
@en
prefLabel
Induction of protective cytoto ...... ssive and active immunization.
@ast
Induction of protective cytoto ...... ssive and active immunization.
@en
P2093
P2860
P356
P1476
Induction of protective cytoto ...... ssive and active immunization.
@en
P2093
C Zimmermann
H Hengartner
M A Bründler
R M Zinkernagel
P2860
P304
P356
10.1084/JEM.187.4.649
P407
P577
1998-02-01T00:00:00Z